Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06054178 · ClinicalTrials.gov registry record · Phase 2
Identification of Nerves Using Fluorescein Sodium
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT06054178: Completed Phase 2 study, sponsored by Stanford University.
NCT06054178 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06054178, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to see if there is benefit in using an IV contrast (sodium fluorescein) to identify nerves during head and neck surgery.
Interventions
- DRUG Fluorescein Sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2024-11-07 |
| Est. Completion | 2025-05-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06054178
The ClinicalTrials.gov registry entry for NCT06054178 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluorescein Sodium is the first listed.
NCT06054178 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06054178 about?
NCT06054178 is a clinical study titled "Identification of Nerves Using Fluorescein Sodium". The purpose of this study is to see if there is benefit in using an IV contrast (sodium fluorescein) to identify nerves during head and neck surgery.
What is the current status of trial NCT06054178?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2024-11-07. Estimated completion is 2025-05-22.
What interventions are being tested in trial NCT06054178?
The interventions under investigation include: Fluorescein Sodium (DRUG).
Who is sponsoring clinical trial NCT06054178?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.